Key Points The transaction involved shares equal to 13% of the stake held before the filing. The disposition was a direct sell of common stock, and the reporting person retains no indirect equity holdings. The sale was executed under a Rule 10b5-1 trading plan adopted by the executive on June 1, 2026. 10 stocks we like better than ICU Medical › Chief Financial Officer Brian Michael Bonnell executed a sale of 9,307 shares of ICU Medical (NASDAQ:ICUI) on Aug. 31, 2026, according to a recent SEC Form 4 filing . Transaction summary Transaction value based on SEC Form 4 weighted average sale price ($172.79); post-transaction value based on Aug. 31, 2026, market close ($172.95). Key questions What was the nature of the execution?
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.